Immunoregulatory changes in Kawasaki disease

Clinical Immunology and Immunopathology

Volumn 84, Issue 3, 1997, Pages 296-306

  Jason, Janine ^a   Gregg, Lynda ^b   Han, Alison ^a   Hu, Andy ^a   Inge, K Leigh ^a   Eick, Angelia ^a   Tham, Irene ^a   Campbell, Robert ^b  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b Children's Healthcare of Atlanta at Egleston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; IMMUNOGLOBULIN; INTERLEUKIN 2 RECEPTOR;

ARTICLE; CELL ADHESION; CHILD; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOLOGICAL MEMORY; IMMUNOREGULATION; IMMUNOTHERAPY; INFANT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VASCULITIS;

EID: 0013591065     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4376     Document Type: Article

References (43)

1. Leung D. Y. M. Immunologic aspects of Kawasaki syndrome. J. Rheumatol. 17:1990;15-18.
2. Kato H., Koike S., Yamamoto M., Ito Y., Yano E. Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. J. Pediatr. 86:1975;892-898.
3. Suzuki A., Tizard E. J., Gooch V., Dillon M. J., Haworth S. G. Kawasaki disease: Echocardiographic features in 91 cases presenting in the United Kingdom. Arch. Dis. Child. 65:1990;1142-1146.
4. Nakamura Y., Fujita Y., Nagai M., Yanagawa H., Imada Y., Okawa S., Kawasaki T., Kato H. Cardiac sequelae of Kawasaki disease in Japan: Statistical analysis. Pediatrics. 88:1991;1144-1147.
5. Dhillon R., Newton L., Rudd P. T., Hall S. M. Management of Kawasaki disease in the British Isles. Arch. Dis. Child. 69:1993;631-638.
6. Furukawa S., Matsubara T., Jujoh K., Yone K., Sugawara T., Sasai K., Kato H., Yabuta K. Peripheral blood monocyte/macrophages and serum tumor necrosis factor in Kawasaki disease. Clin. Immunol. Immunopathol. 48:1988;247-251.
7. Furukawa S., Matsubara T., Motohashi T., Nakachi S., Sasai K., Yabuta K. Expression of FcεR2/CD23 on peripheral blood macrophages/monocytes in Kawasaki disease. Clin. Immunol. Immunopathol. 56:1990;280-286.
8. Terai M., Kohno Y., Niwa K., Toba T., Sakurai N., Nakajima H. Imbalance among T-cell subsets in patients with coronary arterial aneurysms in Kawasaki disease. Am. J. Cardiol. 60:1987;555-559.
9. Furukawa S., Matsubara T., Tsuji K., Okumura K., Yabuta K. Transient depletion of T cells with bright CD11a/CD18 expression from peripheral circulation during acute Kawasaki disease. Scand. J. Immunol. 37:1993;377-380.
10. Barron K., DeCunto C., Montalvo J., Orson F., Lewis D. Abnormalities of immunoregulation in Kawasaki syndrome. J. Rheumatol. 15:1988;1243-1249.
11. Leung D. Y. M., Burns J. C., Newburger J. W., Geha R. S. Reversal of lymphocyte activationin vivo. J. Clin. Invest. 79:1987;468-472.
12. Leung D. Y. M., Siegel R. L., Grady S., Krensky A., Meade R., Reinherz E. L., Geha R. S. Immunoregulatory abnormalities in mucocutaneous lymph node syndrome. Clin. Immunol. Immunopathol. 23:1982;100-112.
13. Furukawa S., Matsubara T., Obara T., Okumura K., Yabuta K. Soluble CD2 levels in serum during acute Kawasaki disease and infectious mononucleosis. J. Infect. Dis. 167:1993;778-779.
14. Shannon K., Fink C. W., Buchanan G. R., Punaro M., Stastny P. Lymphocyte subpopulations in Kawasaki disease. Clin. Exp. Rheumatol. 1:1983;59-62.
15. Furukawa S., Matsubara T., Tsuji K., Motohashi T., Okumura K., Yabuta K. Serum soluble CD4 and CD8 levels in Kawasaki disease. Clin. Exp. Immunol. 86:1991;134-139.
16. Abe J., Kotzin B. L., Jujo K., Melish M. E., Glode M. P., Kohsaka T., Leung D. Y. M. Selective expansion of T cells expressing T-cell receptor variable regions Vβ2 and Vβ8 in Kawasaki disease. Proc. Natl. Acad. Sci. USA. 89:1992;4066-4070.
17. Abe J., Kotzin B. L., Meissner C., Melish M. E., Takahashi M., Fulton D., Romagné F., Malissen B., Leung D. Y. M. Characterization of T cell repertoire changes in acute Kawasaki disease. J. Exp. Med. 177:1993;791-796.
18. Curtis N., Zheng R., Lamb J. R., Levin M. Evidence for a superantigen mediated process in Kawasaki disease. Arch. Dis. Child. 72:1995;308-311.
19. β. Pediatr. Res. 39:1996;264-266.
20. Peitra B. A., DeInocencio J., Giannini E. H., Hirsch R. TCR Vβ family repertoire and T cell activation markers in Kawasaki disease. J. Immunol. 153:1994;1881-1888.
21. Nishiyori A., Sakaguchi M., Kato H., Igarashi H., Miwa K. Toxic shock syndrome toxin-secretingStaphylococcus aureus. Lancet. 343:1994;299-300.
22. N. S. Marchette, S. Kihara, E. Low, X. Cao, J. Martin, M. Melish, 1994, Staphylococcal TSST-1 is not the cause of Kawasaki syndrome in Hawaii, 44, Am. Soc. Microbiol. Washington, DC.
23. Simpson I. J., Skinner M. A., Geursen A., Peake J. S., Abbott W. G., Fraser J. D., Lockwood C. M., Tan P. L. J. Peripheral blood T lymphocytes in systemic vasculitis: Increased T cell receptor Vβ2 gene usage in microscopic polyarteritis. Clin. Exp. Immunol. 101:1995;220-226.
24. Newburger J. W., Takahashi M., Burns J. C., Beiser A. S., Chung K. J., Duffy C. E., Glode M. P., Mason W. H., Reddy V., Sander S. P., Shulman S. T., Wiggins J. W., Hicks R. V., Fulton D. R., Lewis A. B., Leung D. Y. M., Colton T., Rosen F. S., Melish M. E. The treatment of Kawasaki syndrome with intravenous gamma globulin. N. Engl. J. Med. 315:1986;341-347.
25. Newburger J. W., Takahashi M., Beiser A. S., Burns J. C., Bastian J., Chung K. J., Colan S. D., Duffy C. E., Fulton D. R., Glode M. P., Mason W. H., Cody-Meissner H., Rowley A. H., Shulman S. T., Reddy V., Sundel R. P., Wiggins J. W., Colton T., Melish M. E., Rosen F. S. A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N. Engl. J. Med. 324:1991;1633-1639.
26. Rowley A. H., Duffy C. E., Shulman S. T. Prevention of giant coronary artery aneurysms in Kawasaki disease by intravenous gamma globulin therapy. J. Pediatr. 113:1988;290-294.
27. Nagashima M., Matsushima M., Matsuoka H., Ogawa A., Okumura N. High-dose gamma globulin therapy for Kawasaki disease. J. Pediatr. 110:1987;710-712.
28. Jason J., Inge K. L. The effects of mitogens, IL-2, and anti-CD3 antibody on the T-cell receptor Vβ repertoire. Scand. J. Immunol. 43:1996;652-661.
29. Paul L. C., Davidoff A., Paul D. W., Benediktsson H., Issekutz T. B. Monoclonal antibodies against LFA-1VLA-4 inhibit graft vasculitis in rat cardiac allografts. Transplant. Proc. 25:1993;813-814.
30. +. J. Immunol. 154:1995;5293-5301.
31. Amlot P. L., Tahami F., Chinn D., Rawlings E. Activation antigen expression on human T cells. I. Analysis by two-colour flow cytometry of umbilical cord bloodadult bloodlymphoid tissue. Clin. Exp. Immunol. 105:1996;176-182.
32. Ausiello C. M., Urbani F., la Sala A., Funaro A., Malavasi F. CD38 ligation induces discrete cytokine mRNA expression in human cultured lymphocytes. Eur. J. Immunol. 25:1995;1477-1480.
33. Malavasi F., Funaro A., Alessio M., DeMonte L. B., Ausiello C. M., Dianzani U., Lanza F., Magrini E., Momo M., Roggero S. CD38: A multi-lineage cell activation molecule with a split personality. Int. J. Clin. Lab. Res. 22:1992;73-80.
34. +. J. Immunol. 153:1994;952-959.
35. Suciu-Foca N., Rosochacki S. J., Cai J., Reed E., Rubinstein P., King D. W. Immunologicalbiochemical characterization of an epitope of the transferrin receptor involved in the production of interferon-γB-cell growth factor. Cell. Immunol. 110:1987;265-281.
36. Kemp J. D., Thorson J. A., Gomez F., Smith K. M., Cowdery J. S., Ballas Z. K. Inhibition of lymphocyte activation with anti-transferrin receptor Mabs: A comparison of three reagentsfurther studies of their range of effects and mechanism of action. Cell. Immunol. 122:1989;218-230.
37. Morimoto C., Rudd C. E., Letvin N. L., Schlossman S. F. A novel epitope of the LFA-1 antigen which can distinguish killer effectorsuppressor cells in human CD8 cells. Nature. 330:1987;479-482.
38. Sánchez-Madrid F., Corbi A. L. Leukocyte integrins: Structure, function and regulation of their activity. Semin. Cell Biol. 3:1992;199-210.
39. Fan S. T., Brian A. A., Lollo B. A., Mackman N., Shen N. L., Edgington T. S. CD11a/CD18 (LFA-1) integrin engagement enhances biosynthesis of early cytokines by activated T cells. Cell. Immunol. 148:1993;48-59.
40. Chong A. S., Boussy I. A., Graf L. H., Scuderi P. Stimulation of IFN-gammaTNF-alphaTNF-beta secretion in IL-2-activated T cells: Costimulatory roles for LFA-1LFA-2CD44CD45 molecules. Cell. Immunol. 144:1992;69-79.
41. Issekutz T. B. Dual inhibition of VLA-4LFA-1 maximally inhibits cutaneous delayed-type hypersensitivity-induced inflammation. Am. J. Pathol. 143:1993;1286-1293.
42. Takeuchi T., Amano K., Sekine H., Koide J., Abe T. Upregulated expressionfunction of integrin adhesive receptors in systemic lupus erythematosus patients with vasculitis. J. Clin. Invest. 92:1993;3008-3016.
43. Takeuchi T., Aoki K., Koide J., Sekine H., Abe T. Systemic lupus erythematosus with necrotizing vasculitisupregulated expression of VLA-4 antigen. Clin. Rheumatol. 14:1995;370-374.